Areas of tissue destruction (necrosis) or ulceration may develop, and fever and halitosis may be present in severe disease.
You've got a headache and maybe a cough and you may develop a fever, with a temperature of up to 104 degrees, or chills which make you shake, sweating, a sore throat, fatigue - oh, and a blocked nose.
Less commonly, children may develop a fever or be irritable for a short period.
People with MRSA may develop a fever.
At the time of defervescence up to 5% of cases may develop dengue hemorrhagic fever and/or dengue shock syndrome (DHF/DSS).
Infected humans may develop acute Q fever, which is a mild, self-limiting influenza-like illness that is sometimes complicated with pneumonia or hepatitis.
Dengue (DEN-2) patients usually recover fully within days (< 1% mortality), but some individuals, especially those with prior dengue exposure, may develop dengue hemorrhagic fever (DHF).
It is estimated that the disease is a potential threat to almost half of the world's population; some individuals, mostly children, may develop dengue hemorrhagic fever, a severe and often fatal form of the disease.
1– 3 One of the major systemic side effects of rhTNF-α treatment is the induction of a systemic inflammatory response syndrome (SIRS), in which patients may develop tachycardia and fever as a result of increased cardiac output and decreased vascular resistance.
In cases with severe infections, hemorrhagic dengue fever may develop.
